Wanxiang Healthcare Investments is a corporate venture capital firm that focuses on early to growth-stage healthcare technologies, with a particular emphasis on digital health. The firm's strategy involves taking a long-term approach and participating in Series A through Series E funding rounds.
100% of their portfolio is in Healthcare. Their most common stage is series-d (100% of deals).
Portfolio
1
Fund Size
—
Top Stage
Series D
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
 Endotronix, Inc. | Series D | $45M | Sep 2018 |
Top Co-Investors
Last updated: 4 May 2026